.png) |
 |
Recommendations on Treatment with PCSK9 InhibitorsPresented by Carl E. Orringer, MD, FACC, FNLA and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC |
(1).png) |
FOURIER trial: Understanding the Role of PCSK9 Inhibitors in ASCVD PatientsPresented by Daniel Soffer, MD, FNLA, FACP and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC |
Publish Date:
Friday, May 19, 2017 - 15:30